Evidence map›Paper›PMID 32398134›Full record

ArticleBMC infectious diseases2020

An unusual case of dengue shock syndrome complicated by ilio-femoral deep vein thrombosis; a case report.

K M I U Ranasinghe, D Dissanayaka, K Thirumavalavan, M Seneviratne

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC infectious diseases, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Case Report and Review of the Literature: Ischemic Stroke in Dengue Virus Infection.The American journal of tropical medicine and hygiene · 2024
    Review
  5. Article
  6. Article
  7. Case Report: Dengue Hemorrhagic Fever with Ischemic Stroke.The American journal of tropical medicine and hygiene · 2021
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

K M I U RanasingheRegistrar in Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka. indrachaparanasinghe@gmail.com.ORCID http://orcid.org/0000-0002-6179-0734
D DissanayakaPhysician, National Hospital of Sri Lanka, Colombo, Sri Lanka.
K ThirumavalavanPhysician, National Hospital of Sri Lanka, Colombo, Sri Lanka.
M SeneviratnePhysician, National Hospital of Sri Lanka, Colombo, Sri Lanka.
National Hospital of Sri Lanka · LK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDengue fever is a hemorrhagic fever caused by flaviviruses. Hemorrhagic manifestations are well known to be associated with dengue fever, though the thrombotic events are only seldom reported. Underlying pathophysiology of thrombotic events is multifactorial and the management is challenging due to associated thrombocytopenia and bleeding tendency. We report a case of dengue shock syndrome with severe thrombocytopenia complicated by ilio-femoral deep vein thrombosis. CASE PRESENTATION: A 16 year old boy presented with dengue fever. He had dengue shock syndrome after entering the critical phase on the fifth day of the illness. With the recovery from the critical phase he developed deep vein thrombosis involving right external iliac, common femoral and superficial femoral veins. There were no provocative factors other than dengue fever itself. His platelet count was 12,000/μl at the time of diagnosis with deep vein thrombosis. Anticoagulation was started with intravenous unfractionated heparin 500 IU/hour while closely being observed for bleeding complications. 1000 IU/hour dose was commenced with the recovery of the platelet count above 50,000/μl. Thrombophilia screening was negative and he was discharged on warfarin. Venous duplex done after 6 weeks showed normal lower limb venous flow and warfarin was omitted after three months.

conclusionsWith dengue fever, complications like deep vein thrombosis can be easily missed given its rarity and that the major concern is on hemorrhagic complications. Management is challenging due to associated thrombocytopenia and hemorrhagic complications.

Indexed as

Administration, IntravenousAdolescentAnticoagulantsAntigens, ViralDengue VirusFemoral VeinHeparinHumansLower ExtremityMaleSevere DengueThrombocytopeniaTreatment OutcomeVenous ThrombosisWarfarinAnticoagulantsAntigens, ViralHeparinWarfarinDeep vein thrombosisDengueDengue shock syndromeThrombocytopenia

Identifiers

PMID32398134
PMCPMC7216574
OpenAlexW3027974486

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.